SI
PFE icon

Saxon Interests’s Pfizer PFE Stock Holding History

Saxon Interests’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,563
Closed -$254K – 200
2024
Q4 		$254K Buy
9,563
+535
+6% +$14.5K 0.11% 154
2024
Q3 		$261K Buy
9,028
+1,305
+17% +$38.1K 0.12% 147
2024
Q2 		$216K Sell
7,723
-123
-2% -$3.39K 0.1% 154
2024
Q1 		$218K Sell
7,846
-1,725
-18% -$47.9K 0.1% 164
2023
Q4 		$276K Buy
+9,571
New +$289K 0.14% 145
2023
Q3 		– Sell
-8,998
Closed -$330K – 161
2023
Q2 		$330K Buy
8,998
+966
+12% +$37.6K 0.18% 123
2023
Q1 		$328K Sell
8,032
-2
-0% -$86 0.19% 126
2022
Q4 		$389K Sell
8,034
-275
-3% -$13.2K 0.22% 109
2022
Q3 		$367K Buy
8,309
+951
+13% +$46.2K 0.22% 96
2022
Q2 		$386K Sell
7,358
-564
-7% -$28.7K 0.23% 95
2022
Q1 		$410K Buy
7,922
+2,831
+56% +$147K 0.22% 90
2021
Q4 		$289K Buy
+5,091
New +$252K 0.16% 96

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Saxon Interests's PFE Position: Q1 2025 in Review

Saxon Interests sold out of Pfizer (PFE) in Q1 2025, closing a stake of 9,563 shares — an estimated $254K sold.

Saxon Interests first reported a position in PFE in Q4 2021 and held it in 12 quarters. The position peaked at $410K in Q1 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Saxon Interests reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Saxon Interests sold 9,563 Pfizer shares in Q1 2025, an estimated $254K.
  • Saxon Interests first reported a position in Pfizer in Q4 2021 and held it in 12 quarters.
  • Saxon Interests's Pfizer position peaked at $410K in Q1 2022.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Saxon Interests's 13F filing for Q1 2025, filed 25 Apr 2025.